Home › Conditions › Deep Vein Thrombosis
Cardiology
Deep Vein Thrombosis
Two-level Wells score first: ≥2 (likely) → proximal leg vein US (interim anticoagulation if scan >4h away); <2 (unlikely) → D-dimer. A positive D-dimer never diagnoses DVT. First-line treatment: DOAC; provoked = 3 months. Beware phlegmasia cerulea dolens — the limb-threatening blue leg.
NICE NG158 VTE Pathway
The pathway
Wells score
- Cancer, immobility/surgery, tenderness, swelling ≥3cm difference, oedema, collaterals, previous DVT
- ≥2 likely / <2 unlikely
- Subtract 2 if another diagnosis is at least as likely
Right test for the group
- Likely → US within 4h; if delayed, D-dimer then interim therapeutic anticoagulation and US within 24h
- Unlikely → D-dimer; negative excludes DVT, positive → proximal US within 4h (or interim therapeutic anticoagulation + US within 24h).
- If D-dimer result is delayed beyond 4h, give interim therapeutic anticoagulation while awaiting it
- Negative US in the likely group → D-dimer; if positive, stop interim therapeutic anticoagulation (continue anticoagulation needed for another indication) and repeat US in 6–8 days
- Post-op/cancer: a positive D-dimer is nonspecific
Interim anticoagulation
- Scan delayed >4h → treatment-dose DOAC/LMWH
- Check bleeding risk + recent surgery with senior
Treat confirmed DVT
- Apixaban 10mg BD ×7d → 5mg BD (or rivaroxaban regimen)
- Provoked: 3 months; unprovoked: ≥3 months + review
- Cancer: DOAC or LMWH per subtype
Limb-threat check
- Dusky blue, agonising, massive swelling = phlegmasia
- Urgent vascular/IR: lysis or thrombectomy
Counsel & follow up
- PE symptoms → immediate help
- Post-thrombotic syndrome (20–50%)
- 3-month anticoagulation review is essential
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Apixaban | 10mg BD ×7 days → 5mg BD | PO | First-line; no heparin bridge or routine coagulation tests. Monitor renal function, blood count and bleeding. |
| Rivaroxaban | 15mg BD ×21 days → 20mg OD | PO | Alternative first-line. With food. |
| Enoxaparin | 1.5mg/kg OD or 1mg/kg BD | SC | OD for uncomplicated low-recurrence-risk DVT; BD for higher-risk patients, including cancer, obesity or symptomatic PE. Adjust for renal impairment. |
When to escalate
- Suspected phlegmasia — vascular surgery/IR immediately
- Bilateral DVT or IVC extension — imaging + specialist input
- DVT with concurrent PE symptoms — treat as PE pathway
- Anticoagulation contraindicated — discuss IVC filter with specialists
Reference: NICE NG158 / BTS + local VTE policy
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.